111 related articles for article (PubMed ID: 22541098)
1. [Abnormal expression of microRNA-124 in patients with leukemia or myelodysplastic syndrome and its significance].
Xia Q; Hu J; Meng YS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):358-61. PubMed ID: 22541098
[TBL] [Abstract][Full Text] [Related]
2. [Experimental study of SHP-1 promoter methylation in myelodysplastic syndromes and its related mechanism].
Zhang YZ; Zhao DD; Zhao WP; Zhao HF; Zhao ZG; Wang YF; Wu XX; Han XP; Da WM
Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):108-12. PubMed ID: 22730659
[TBL] [Abstract][Full Text] [Related]
3. [Methylation status of ZO-1 gene in patients with myelodysplastic syndrome].
Kang HY; Wang C; Dou LP; Qing Y; Han XP; Sun JF; Liu CH; Lu XC; Liu Y; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):70-3. PubMed ID: 18315903
[TBL] [Abstract][Full Text] [Related]
4. [Detection of methylation levels of multi-genes by real-time PCR in patients with myelodysplastic syndrome].
Wang YC; DU X; Geng SX; Li YY; Weng JY; Lu ZS; Zhong LY; Deng CX; Lai PL; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):254-8. PubMed ID: 21569709
[TBL] [Abstract][Full Text] [Related]
5. [Reactivated Expression of MicroRNA-124 in Patients with Myelodysplastic Syndromes after Demethylating Therapy].
Meng YS; Gao S; Hua FL; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1807-1810. PubMed ID: 28024498
[TBL] [Abstract][Full Text] [Related]
6. Pyrosequencing quantified methylation level of miR-124 predicts shorter survival for patients with myelodysplastic syndrome.
Wang H; Zhang TT; Jin S; Liu H; Zhang X; Ruan CG; Wu DP; Han Y; Wang XQ
Clin Epigenetics; 2017; 9():91. PubMed ID: 28861128
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation of MIR-378 5'-flanking region predicts poor survival in young patients with myelodysplastic syndrome.
Wu DH; Zhu XW; Wen XM; Zhang YY; Ma JC; Yao DM; Zhou JD; Guo H; Wu PF; Zhang XL; Qiu HC; Lin J; Qian J
Mol Genet Genomic Med; 2020 Jan; 8(1):e1067. PubMed ID: 31833222
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of miR-196b-5p is significantly associated with the progression of myelodysplastic syndrome.
Wen J; Huang Y; Li H; Zhang X; Cheng P; Deng D; Peng Z; Luo J; Zhao W; Lai Y; Liu Z
Int J Hematol; 2017 Jun; 105(6):777-783. PubMed ID: 28224273
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome.
Choi Y; Hur EH; Moon JH; Goo BK; Choi DR; Lee JH
Korean J Intern Med; 2019 Mar; 34(2):390-400. PubMed ID: 29132200
[TBL] [Abstract][Full Text] [Related]
10. [Expression of WT1 and PRAME gene in bone marrow and peripheral blood samples of patients with myelodysplastic syndrome].
Lu D; Qin YZ; Li LD; Shi HX; Lai YY; Liu YR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):370-6. PubMed ID: 24763007
[TBL] [Abstract][Full Text] [Related]
11. [Differential expression of miR-143 in bone marrow cells between acute leukemia patients and normal people and its significance].
Zhang YY; Zheng YQ; Li XY; Wu DS; Xie SL; Shen JZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):308-11. PubMed ID: 21518477
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
13. [Significance of methylation status of zo-1 gene in differential diagnosis for myelodysplastic syndrome].
Kang HY; Wang XR; Wang LL; Wang C; Cen J; Gao L; Liu Y; Li YH; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):76-80. PubMed ID: 21362226
[TBL] [Abstract][Full Text] [Related]
14. [Expression of TFPI-2 gene and its promoter methylation in acute myeloid leukemia].
Shao LL; Fan J; Wang R; Feng LL; Zhen CQ; Sui XH; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):920-6. PubMed ID: 25130804
[TBL] [Abstract][Full Text] [Related]
15. [Expressive changes of CD4(+)T cell subset transcription factors in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia and their clinical significances].
Feng XM; Xu HZ; Zhang JY; Yin DM; Liu MM; Sui XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1038-42. PubMed ID: 25130824
[TBL] [Abstract][Full Text] [Related]
16. [mRNA expression of telomere protection protein TIN2 and POT1 in bone marrow of patients with myelodysplastic syndrome].
Ye F; He YM; Li GX; Wang LN; Jia N; Ma RX; Ma YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):110-5. PubMed ID: 23484702
[TBL] [Abstract][Full Text] [Related]
17. Absence of NPM1 promoter hypermethylation in human myelodysplastic syndrome.
Cheng YY; Chau D; Chan T; Gill H; Liang R; Kwong YL; Tse E
J Clin Pathol; 2010 Nov; 63(11):1008-11. PubMed ID: 20924036
[TBL] [Abstract][Full Text] [Related]
18. [Expression of tumor suppressor gene pten in patients with myelodysplastic syndrome and acute myeloid leukemia].
Zou XL; Liu T; Meng WT; Huang XO
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1086-90. PubMed ID: 18928601
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
[TBL] [Abstract][Full Text] [Related]
20. Quantitative comparison of CDKN2B methylation in pediatric and adult myelodysplastic syndromes.
Kim M; Kook H; Park HJ; Ahn HS; Lee KC; Lee KS; Park SK; Lim JY; Kim HK; Han DK; Lee DS;
Acta Haematol; 2013; 130(2):115-21. PubMed ID: 23571652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
